The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2015
Filed:
Mar. 20, 2008
Applicants:
Jean-luc Maloisel, Uppsala, SE;
Bo-lennart Johansson, Uppsala, SE;
Inventors:
Jean-Luc Maloisel, Uppsala, SE;
Bo-Lennart Johansson, Uppsala, SE;
Assignee:
GE Healthcare Bio-Sciences AB, Uppsala, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07H 1/00 (2006.01); B01D 15/38 (2006.01); B01D 15/08 (2006.01); B01J 20/289 (2006.01); B01D 15/32 (2006.01); B01J 20/286 (2006.01); B01J 20/32 (2006.01); C07K 1/20 (2006.01); B01J 20/26 (2006.01); B01D 15/36 (2006.01);
U.S. Cl.
CPC ...
B01J 20/289 (2013.01); B01D 15/32 (2013.01); B01D 15/327 (2013.01); B01D 15/361 (2013.01); B01D 15/3804 (2013.01); B01D 15/3847 (2013.01); B01J 20/286 (2013.01); B01J 20/3285 (2013.01); C07K 16/00 (2013.01); C07K 1/20 (2013.01); B01J 20/262 (2013.01); B01J 20/267 (2013.01); B01J 20/3212 (2013.01); B01J 20/3219 (2013.01); B01J 20/3251 (2013.01); B01J 20/3272 (2013.01); B01J 20/328 (2013.01); B01J 2220/54 (2013.01); B01J 2220/58 (2013.01);
Abstract
The present invention relates to a separation matrix comprised of a porous or non-porous support to which ligands have been immobilized, wherein said ligands comprise at least one aliphatic sulfamide. The invention also relates to a chromatography column that contains the described separation matrix, as well as to a method of isolating immunoglobulins, such as IgG, Fab fragments, fusion proteins containing immunoglobulins etc, by adsorption to a separation matrix that comprises the aliphatic sulfamide ligands of the invention.